Outlook Therapeutics
OTLK
OTLK
56 hedge funds and large institutions have $89.9M invested in Outlook Therapeutics in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
66% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 47
Holders
56
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$19.3M | |
| 2 | +$17.7M | |
| 3 | +$8.53M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$6.82M |
| 5 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$5.97M |
Top Sellers
| 1 | -$459K | |
| 2 | -$171K | |
| 3 | -$90.4K | |
| 4 |
CKAIS
Christensen King & Associates Investment Services
Richland,
Washington
|
-$64.5K |
| 5 |
Barclays
London,
United Kingdom
|
-$63.6K |